Integrative metabolic profile of myelodysplastic syndrome based on UHPLC–MS

Myelodysplastic syndrome (MDS) is a neoplastic disease originating from hematopoietic stem cells. Currently, hematopoietic stem cell transplantation (HSCT) is the most effective cure, although lenalidomide, azacytidine, and decitabine have been applied to relieve symptoms of MDS. The purpose of this...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Biomedical chromatography 2021-09, Vol.35 (9), p.e5136-n/a
Hauptverfasser:	Yuan, Yunxia, Zhao, Jing, Li, Taifeng, Ji, Zhengchao, Xin, Ying, Zhang, Siyao, Qin, Feng, Zhao, Longshan
Format:	Artikel
Sprache:	eng
Schlagworte:	biomarkers metabolic pathways metabolomics myelodysplastic syndrome UHPLC–MS
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!